...
首页> 外文期刊>International Journal of Polymeric Materials >Cyto- and genotoxicity evaluation of the biomedical polyesters obtained in the presence of new zinc catalytic systems
【24h】

Cyto- and genotoxicity evaluation of the biomedical polyesters obtained in the presence of new zinc catalytic systems

机译:在新锌催化系统存在下获得的生物医学聚酯的细胞和遗传毒性评价

获取原文
获取原文并翻译 | 示例
           

摘要

A preliminary evaluation of cyto- and genotoxicity of the biomedical polyesters obtained in the presence of new zinc catalytic systems was performed. A series of biomedical poly(epsilon-caprolactone)s (PCLs) and poly(rac-lactide)s (PLAs) synthesized in the presence of diethylzinc/propyl gallate or diethylzinc/gallic acid catalytic systems were tested using the luminescent bacterium Vibrio fischeri, the ciliated protozoan Spirostomum ambiguum as well as Salmonella typhimurium TA1535. The main goal of our work was to find the correlation between the zinc catalyst content in the synthesized products and cyto- or genotoxicity of the synthesized polyesters or their degradation products. To remove the metal catalyst residue, the obtained polyesters were subjected to the purification procedure. The Zn content in the synthesized polymers was determined by flame atomic absorption spectrometry. It was found that the purified PCLs and PLAs which contained the Zn below ca. 450ppm were not cyto- or genotoxic. Importantly, the Zn content in the synthesized PCLs and PLAs after the second polymer precipitation was significantly reduced to 14ppm. We believe that our results are satisfactory enough for the biomedical applications, i.e., for the synthesis of biomedical polyesters used as drug delivery systems.
机译:进行新的锌催化系统中获得的生物医学聚酯的细胞和遗传毒性的初步评价。使用发光细菌vibrioFischeri测试在存在二乙基锌/丙酸盐酯或二乙基锌/无碱酸催化体系中合成的一系列生物医学聚(ε-己内酯)(PCLS)和聚(RAC-丙交酯)(PLA),纤毛的原生动物螺旋蛋白酶含糊不清,以及沙门氏菌Typhimurium ta1535。我们作品的主要目的是在合成的产品和合成的聚酯或其降解产物的合成产品和细胞毒性或遗传毒性中找到锌催化剂含量之间的相关性。为了除去金属催化剂残余物,对所得的聚酯进行纯化方法。合成聚合物中的Zn含量通过火焰原子吸收光谱法测定。发现纯化的PCL和PCLS和PLA,其包含在CA下方的Zn. 450ppm不是细胞或遗传毒性。重要的是,第二聚合物沉淀后合成的PCLS和PLA中的Zn含量显着降低至14ppm。我们认为,我们的结果足以让生物医学应用,即用于合成作为药物递送系统的生物医学聚酯的合成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号